[Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001855:Bone Marrow Diseases / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone
Caratteristiche clinico-ematologiche e tolleranza alla MOPP dei pazienti con linfoma di Hodgkin a localizzazione midollare.